[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.21. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 25, 1980

Anticoagulant Therapy and Myocardial Infarction-Reply

Author Affiliations

The Johns Hopkins University School of Hygiene and Public Health Baltimore
Ohio State University Columbus
Public Health Service Hospital Baltimore

JAMA. 1980;243(16):1629-1630. doi:10.1001/jama.1980.03300420013008

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In Reply.—  We agree with Dr Selzer in wanting a study in which "anticoagulant therapy or its lack is the only variable." This is, in fact, the reason that we specifically proposed that a well-designed clinical trial be conducted.We cannot, however, agree with his contention that unless an experimental trial is conducted, it is worthless to analyze observational data. He raises the possibility that the lower case-fatality rate in our anticoagulated group could have been from a spuriously high rate in the nonanti-coagulated group. However, since our sample included nearly all hospitalized myocardial infarction patients in Baltimore, the possibility of selection biases that might have artifactually affected mortality is unlikely. That our figures do not match what Dr Selzer believes are "the best mortality figures" may simply reflect the fact that studies done in different populations rarely, if ever, yield identical results or that the "best available" figures may

×